Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v4-FR
Language English French
Date Updated 2024-10-02 2024-09-17
Drug Identification Number 00010405 00010405
Brand name TEGRETOL TEGRETOL
Common or Proper name TEGRETOL TEGRETOL
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients CARBAMAZEPINE CARBAMAZEPINE
Strength(s) 200MG 200MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100'S 100'S
ATC code N03AF N03AF
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2024-09-27 2024-09-27
Actual start date 2024-10-01
Estimated end date 2024-10-16 2024-10-16
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments Product on allocation to minimize patient impact. Product on allocation to minimize patient impact.
Health Canada comments